1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Synageva BioPharma Corp (GEVA) SVP, CFO Carsten Boess sells 9,927 Shares

January 22, 2013 | About:

SVP, CFO of Synageva BioPharma Corp (NASDAQ:GEVA) Carsten Boess sells 9,927 shares of GEVA on 01/16/2013 at an average price of $49.12 a share.

Synageva Biopharma Corp has a market cap of $1.23 billion; its shares were traded at around $50.74 with and P/S ratio of 83.8.

This is the annual revenues and earnings per share of GEVA over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of GEVA.


CEO Recent Trades:



  • President & CEO Sanj K Patel sold 60,000 shares of GEVA stock on 12/17/2012 at the average price of 46.21. Sanj K Patel owns at least 1,317 shares after this. The price of the stock has increased by 9.8% since.
  • President & CEO Sanj K Patel sold 35,000 shares of GEVA stock on 12/05/2012 at the average price of 48.92. Sanj K Patel owns at least 1,317 shares after this. The price of the stock has increased by 3.72% since.
  • President & CEO Sanj K Patel sold 35,000 shares of GEVA stock on 12/03/2012 at the average price of 49.34. Sanj K Patel owns at least 1,317 shares after this. The price of the stock has increased by 2.84% since.
  • President & CEO Sanj K Patel sold 70,000 shares of GEVA stock on 09/04/2012 at the average price of 49.47. Sanj K Patel owns at least 1,317 shares after this. The price of the stock has increased by 2.57% since.

CFO Recent Trades:



  • SVP, CFO Carsten Boess sold 9,927 shares of GEVA stock on 01/16/2013 at the average price of 49.12. The price of the stock has increased by 3.3% since.
  • SVP, CFO Carsten Boess sold 9,927 shares of GEVA stock on 10/16/2012 at the average price of 50.13. The price of the stock has increased by 1.22% since.

This is the insider trade history vs. stock price of GEVA. For the complete insider trading history of GEVA, click here.




Directors and Officers Recent Trades:



  • Director Thomas J Tisch bought 21,039 shares of GEVA stock on 01/09/2013 at the average price of 47.53. Thomas J Tisch owns at least 751,995 shares after this. The price of the stock has increased by 6.75% since.
  • Director, 10% Owner Felix Baker bought 859,720 shares of GEVA stock on 01/04/2013 at the average price of 47.53. Felix Baker owns at least 1,736,565 shares after this. The price of the stock has increased by 6.75% since.
  • Director, 10% Owner Julian Baker bought 859,720 shares of GEVA stock on 01/04/2013 at the average price of 47.53. Julian Baker owns at least 1,737,085 shares after this. The price of the stock has increased by 6.75% since.
  • SVP, Chief Medical Officer Anthony Quinn sold 5,553 shares of GEVA stock on 01/17/2013 at the average price of 50.07. Anthony Quinn owns at least 15,035 shares after this. The price of the stock has increased by 1.34% since.
  • SVP, Product Development Mark Alan Goldberg sold 4,417 shares of GEVA stock on 01/02/2013 at the average price of 47.52. The price of the stock has increased by 6.78% since.


For the complete insider trading history of GEVA, click here.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Select portfolio(s):

  • Loading...

Why you are interested?

Your selection and notes will be stored in your portfolio.

Login to add portfolio
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK